Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
methadone hydrochloride
|
| gptkbp:administeredBy |
oral route
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
gptkb:N07BC02
|
| gptkbp:brand |
gptkb:methadone
|
| gptkbp:controlledSubstanceSchedule |
gptkb:Schedule_II_(US)
|
| gptkbp:form |
oral solution
|
| https://www.w3.org/2000/01/rdf-schema#label |
Methadose
|
| gptkbp:legalStatus |
controlled substance
|
| gptkbp:marketedAs |
gptkb:Mallinckrodt_Pharmaceuticals
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:riskFactor |
addiction
overdose QT prolongation |
| gptkbp:sideEffect |
nausea
constipation drowsiness respiratory depression |
| gptkbp:usedFor |
chronic pain
opioid dependence |
| gptkbp:bfsParent |
gptkb:methadone
gptkb:Methadone |
| gptkbp:bfsLayer |
6
|